C4 Therapeutics
CCCC
#8189
Rank
โ‚ฌ0.21 B
Marketcap
2,23ย โ‚ฌ
Share price
1.97%
Change (1 day)
-43.94%
Change (1 year)

Revenue for C4 Therapeutics (CCCC)

Revenue in 2025 (TTM): โ‚ฌ26.71 Million

According to C4 Therapeutics's latest financial reports the company's current revenue (TTM ) is โ‚ฌ25.86 Million. In 2024 the company made a revenue of โ‚ฌ34.19 Million an increase over the revenue in the year 2023 that were of โ‚ฌ18.77 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for C4 Therapeutics from 2020 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) โ‚ฌ26.71 M-21.87%
2024 โ‚ฌ34.19 M82.12%
2023 โ‚ฌ18.77 M-35.23%
2022 โ‚ฌ28.98 M-28.29%
2021 โ‚ฌ40.42 M49.8%
2020 โ‚ฌ26.98 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ORIC Pharmaceuticals
ORIC
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA